WORK Medical shifts executive offices to New Zealand
WORK Medical Technology Group Ltd has created a wholly-owned New Zealand subsidiary, WORK MEDICAL TECHNOLOGY LIMITED, which will act as its operations and management headquarters and help expand business in New Zealand and Australia.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
6-K
Rhea-AI Filing Summary
WORK Medical Technology Group Ltd has created a wholly-owned New Zealand subsidiary, WORK MEDICAL TECHNOLOGY LIMITED, which will act as its operations and management headquarters and help expand business in New Zealand and Australia. The company now lists its principal executive offices at 1/88 Cook Street in Auckland, New Zealand, and the prior executive office in China is no longer treated as a principal executive office.
This update is furnished on a Form 6-K and is incorporated by reference into the company’s existing Form F-3 registration statement, becoming part of that shelf registration from the date of filing.
Key Figures
Ownership of NZ subsidiary: 100% of issued and outstanding shares
Subsidiary establishment date: May 25, 2026
Form 6-K signature date: May 27, 2026
3 metrics
Ownership of NZ subsidiary
100% of issued and outstanding shares
Indirectly held through wholly-owned BVI subsidiary
Subsidiary establishment date
May 25, 2026
Date WORK MEDICAL TECHNOLOGY LIMITED was established
Form 6-K signature date
May 27, 2026
Date the report was signed by the CEO
Key Terms
foreign private issuer, wholly-owned subsidiary, principal executive offices, Form F-3, +1 more
5 terms
foreign private issuer regulatory
"FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT RULE 13a-16"
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.
wholly-owned subsidiary financial
"the Company established a wholly-owned subsidiary, WORK MEDICAL TECHNOLOGY LIMITED"
A wholly-owned subsidiary is a company whose entire ownership is held by another company, called the parent, so the parent controls all shares, board appointments and major decisions. For investors this matters because the subsidiary’s profits, losses, assets and liabilities are treated as part of the parent’s financial picture, affecting valuation and risk exposure — imagine a parent owning a single storefront outright and consolidating its receipts and bills into the parent’s books.
principal executive offices regulatory
"The Company’s principal executive offices are currently located at 1/88 Cook St"
Form F-3 regulatory
"incorporated by reference into the registration statement of the Company on Form F-3"
Form F-3 is a U.S. securities filing that lets eligible foreign companies pre-register and then quickly sell shares or other securities to raise money, because they already meet ongoing reporting and size tests. For investors it signals that the company is up-to-date with regulatory disclosure and has an efficient way to issue new securities — similar to a pre-approved credit line — which can mean faster capital raises but also potential dilution of existing holdings.
registration statement regulatory
"incorporated by reference into the registration statement of the Company on Form F-3"
A registration statement is a formal document that companies file with a government agency to offer new shares of stock to the public. It provides essential information about the company's finances, operations, and risks, helping investors make informed decisions. Think of it as a detailed product description that ensures transparency and trust before buying into a company.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did WORK Medical Technology Group (WOK) report in this Form 6-K?
WORK Medical reported a change in its corporate setup and headquarters. It established a wholly-owned New Zealand subsidiary to serve as its operations and management headquarters and confirmed its principal executive offices are now in Auckland, replacing a previously used executive office in China.
What is WORK MEDICAL TECHNOLOGY LIMITED and how is it owned?
WORK MEDICAL TECHNOLOGY LIMITED is a private limited liability company incorporated in New Zealand. It is a wholly-owned subsidiary, with WORK Medical Technology Group Ltd indirectly holding 100% of its issued and outstanding shares through a wholly-owned BVI subsidiary, Work Medical Technology Group Limited.
Where are WORK Medical Technology Group’s principal executive offices now located?
The company’s principal executive offices are now at 1/88 Cook St, Auckland City, 1001, New Zealand. This Auckland location is described as the current principal office, and the company provides a contact phone number of +1 949-818-3667 for communication.
What happened to WORK Medical’s previous executive office in China?
The executive office previously maintained in China is no longer used as a principal executive office. The filing does not describe operational impacts, but it clearly states the China office has lost its status as a principal executive office in favor of the New Zealand location.
How does this Form 6-K relate to WORK Medical’s Form F-3 shelf registration?
The Form 6-K is deemed incorporated by reference into WORK Medical’s registration statement on Form F-3 (File No. 333-289943). This means the information about the new subsidiary and principal executive offices becomes part of that registration from the filing date, unless later superseded.
What regional focus does the new New Zealand subsidiary have for WORK Medical (WOK)?
The New Zealand subsidiary is intended to act as the operations and management headquarters and to actively expand WORK Medical’s business in New Zealand and Australia. This points to a clearer regional focus in Australasia for the company’s operational leadership and growth efforts.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates